Public Policy Law360 provides breaking news and analysis across the public policy spectrum. Coverage includes state, federal, and international legislation, agency rulemaking, advocacy initiatives, and government relations, as well as legal challenges to laws and regulations.
The U.S. Food and Drug Administration released draft guidance Friday outlining ways drug companies can develop new medications to treat opioid addiction, focusing on how companies can create modified-release drugs that are either implanted or injected.
As their industry gains acceptance and a greater foothold in the legal marketplace, commercial litigation financing firms are finding themselves not only helping Davids level the playing field, but also Goliaths with respect to better managing risk and deploying their resources more strategically.
Next week, the U.S. Supreme Court will hear oral arguments over the extent of the president's power to control immigration policy and whether President Donald Trump has shown anti-Muslim animus in a case challenging the most recent version of his travel ban. With all eyes turning to the justices, here is a play-by-play of how we got here.
A Pennsylvania court agreed on Friday that a company that lost out on a potentially lucrative cannabis dispensary permit needed to exhaust administrative remedies before it could file suit challenging the constitutionality of the application process for the state’s new medical marijuana program.
Among the proposed amendments to Rule 23 of the Federal Rules of Civil Procedure, which are scheduled to take effect Dec. 1, 2018, are specific requirements related to “front-loading.” They outline the process for seeking preliminary court approval of class action settlements and related notice plans, say Shandarese Garr and Niki Mendoza of Garden City Group LLC.